VIM and lung cancer: Rahman et al. [15] showed that small EVs released from highly metastatic lung cancer cells or those from late-stage lung cancer serum induce EMT, a process resulting in the migration, invasion, and metastasis of cancer cells, and upregulate vimentin, concluding that small EVs may drive the metastatic spread of lung cancer.